11/24/2015 | CVIG | Fitch puts Allergan on positive watch
|
11/23/2015 | CVIG | Moody’s reviews Allergan, Actavis, Forest
|
5/5/2015 | EMHYMUPFPV | Market Commentary: AbbieVie brings $16.7 billion deal; AT&T, Microsoft improve; Exxon, Canadian Pacific Rail soft
|
5/5/2015 | IG | Market Commentary: AbbieVie brings $16.7 billion deal; AT&T, Microsoft improve; Exxon, Canadian Pacific Rail soft
|
3/4/2015 | EMHYMUPFPV | Market Commentary: Primary rush continues as Burlington Northern, Cades, CBA price; Burlington, Apple firm
|
3/4/2015 | IG | Market Commentary: Primary rush continues with Burlington Northern, Cades, CBA; Burlington Northern, Apple firm
|
3/3/2015 | IG | Market Commentary: Actavis megadeal prices; Exxon upsizes; Exxon trades; AT&T firms; Verizon mixed
|
3/3/2015 | IG | New Issue: Actavis prices $21 billion 10-part offering of senior notes
|
3/3/2015 | IG | Actavis sets guidance for 10-part bond offering; pricing Tuesday; around $20 billion size eyed
|
3/2/2015 | IG | Market Commentary: MetLife, Discover, American Airlines price; Actavis jumbo bond on deck; Discover, MetLife firm
|
3/2/2015 | IG | Actavis to price around $20 billion of bonds in nine parts Tuesday to fund Allergan acquisition
|
7/1/2014 | BKHYIG | Moody's lifts Forest Labs from junk
|
6/10/2014 | BKIG | Moody's rates Actavis notes Baa3
|
2/20/2014 | SP | New Issue: UBS prices $846,000 phoenix autocallable notes linked to Actavis
|
2/11/2014 | SP | New Issue: JPMorgan prices $610,000 autocallable contingent interest notes linked to Actavis
|
2/5/2014 | SP | JPMorgan to price capped return enhanced notes linked to pharma stocks
|
2/4/2014 | SP | JPMorgan plans autocallable contingent interest notes tied to Actavis
|
10/22/2013 | HYLM | Actavis to redeem all $450 million of its 5% senior notes due 2014
|